The themes Elevance Health is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
De omzetaandelen zijn schattingen voor year ended December 31, 2025, geen cijfers uit een ingediend rapport.
Employer and individual health plans
Medical insurance plans sold to employers and individuals, with members using contracted doctors and hospitals or paying different amounts for out-of-network care.
Medicare plans
Health coverage for people eligible for Medicare, including Medicare Advantage plans that provide a managed-care alternative to traditional Medicare.
Medicaid plans
State-sponsored health coverage for eligible low-income people, older adults, and people with disabilities.
Employer health-plan administration
Claims processing, access to a network of doctors and hospitals, and care-management services for employers that pay their workers’ medical claims themselves.
CarelonRx pharmacy services
Prescription claims processing, drug-coverage management, pharmacy networks, home delivery, specialty pharmacies, and infusion services.
Carelon Health and Carelon Insights services
Care and support for people with complex health needs, including behavioral health and in-home or virtual care, alongside services that help health plans and providers manage care and process claims.
Elevance Health collects premiums for health plans covering individuals, employees, and people enrolled in Medicare and Medicaid. It also administers health plans funded by employers and sells pharmacy and care services to its own health plans and outside customers. Its affiliated health plans served 44.9 million medical members (June 30, 2026, high).
Gebouwd uit de eigen deponeringen van Elevance Health, Inc. bij de Amerikaanse toezichthouder Securities and Exchange Commission (SEC). De cijfers zijn zoals gerapporteerd, met de historie per aandeel herrekend naar de huidige aandelenbasis. Dit beschrijft een bedrijf — het is geen beleggingsadvies en geen aanbeveling om iets te kopen of te verkopen.
US$ 429,55-0,1%slot 13 nov
Cijfers tot en met 30 september 2026, uit de 10-Q ingediend op 21 oktober 2026
Elevance Health sells health insurance to individuals, employers, and government programs, plus pharmacy and care services to health plans and patients.
Grade C
De balk onder de koers toont het cijfer op elke datum, alleen gebaseerd op de stukken die toen al openbaar waren.
Toont 2 van 41 kwartalen van de cijferhistorie van Elevance Health, Inc.. De andere 39 lopen terug tot november 2016.